MyFinsight
Home
Blog
About
Net loss
-$131,005K
(23.79%↑ Y/Y)
Income tax benefit
-$1K
Loss before income
tax benefit
-$131,006K
(23.79%↑ Y/Y)
Other income (loss),
net
$3,962K
(-8.50%↓ Y/Y)
License And Service
$7,303K
(-61.77%↓ Y/Y)
Grant
$367K
(205.83%↑ Y/Y)
Loss from operations
-$134,968K
(23.41%↑ Y/Y)
Total revenue
$7,670K
(-60.10%↓ Y/Y)
Total operating costs
and expenses
$142,638K
(-27.02%↓ Y/Y)
Research and development
$89,614K
(-30.34%↓ Y/Y)
General and
administrative
$41,533K
(-10.97%↓ Y/Y)
Cost of revenue
$11,491K
(-43.00%↓ Y/Y)
Back
Back
Income Statement
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
source: myfinsight.com
RECURSION PHARMACEUTICALS, INC. (RXRX)
6556d670e8da976dc91d11c4_Recursion Logo Horizontal Black-svg
RECURSION PHARMACEUTICALS, INC. (RXRX)